...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: from IR/Chris

Thanks.  And Thanks to Koo-Koo2.  I just don't recall seeing that 6% before.

 

 

Share
New Message
Please login to post a reply